BrainsWay Enhances Senior Leadership with Promotion and New Executive Addition

PATTERSON, N.J. and JERUSALEM, May 06, 2020 - BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Hadar Levy has been promoted to Senior Vice President and General Manager of North America, and Judith Huber has been appointed the Company’s Senior Vice President and Chief Financial Officer, effective May 11, 2020. Mr. Levy will oversee BrainsWay’s North American business, including sales, operations, customer service, field engineering, and customer training. He is the Company’s current Chief Financial Officer and Chief Operating Officer. Ms. Huber has more than 30 years of experience in strategic and financial planning, financial reporting, financial analysis, budgeting, auditing, capital raising, and investor relations.

“I am very pleased to announce Hadar’s promotion to Senior Vice President and General Manager of North America, the geography currently responsible for over 90 percent of our revenues. Hadar is an integral leader at BrainsWay and I am excited that he has agreed to take on these expanded responsibilities,” said Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay. “Hadar has been with the Company for nearly six years, and has been a key contributor to our strong growth and the transformation of our business model.”

“Judy is a veteran finance professional and her addition strengthens our overall management team. She has held a multitude of financial leadership positions in both private and public companies,” stated Dr. von Jako. “She has extensive experience overseeing the finance function at various medical technology companies, managing the external financial reporting process, and has led multiple financings. Judy is a proven leader and we look forward to her contributions to our already strong financial infrastructure.”

“I am thrilled to lead the financial operations for this growing and dynamic company,” said Ms. Huber. “Demand for the Deep Transcranial Magnetic Stimulation system (Deep TMS) continues to grow in multiple large indications, and I am eager to work with the management team to further accelerate commercialization and market adoption in the U.S. and around the globe. I look forward to leveraging my financial expertise to support BrainsWay’s goal of creating long-term shareholder value.”

Most recently, Ms. Huber served as CFO of NinePoint Medical, Inc., a privately-held, advanced image guidance company, where she led multiple financings. Prior to NinePoint Medical, Ms. Huber served as CFO of ConforMis, Inc., a patient-specific orthopedic implant company, where she established the company’s finance infrastructure. Previously, Ms. Huber served as Vice President and Corporate Controller of NxStage Medical, a home hemodialysis company recently acquired by Fresenius Medical, where she oversaw the company’s financial reporting to the Securities and Exchange Commission. Earlier in her career, Ms. Huber held increasingly senior finance roles with C.R. Bard within their cardiology and surgical divisions.

Ms. Huber holds an MBA from Babson College and a B.S. degree in Accounting from the State University of New York at Geneseo.